The only information being presented on grade is some comments in research forecasts. It a safe bet that a lot of the current product isn't getting to the 32-33% range or E25 would be putting it in their quarterlies that they have achieved PFS grades and are working on volumes.
I'm not sure if the original designs had a gravity concentrator system like DMS, but once they achieved good test results with their flowsheet of Dig, Crush, Wash, Size grade & Optical sort (ref 23 Mar 2020), they when with that. It would appear the test sample was washed to a much cleaner state than the log washer does. This means that within the test work the optical sorter didn't have the clay distortions that can cause a misread.
I'm not sure if its a typo, but my understanding is that DMS is a sub-category of a gravity concentrator circuit. DMS uses gravity to select different material densities but does this by having a liquid that is a lot heavier than water. Where water works to separate pumice from other rocks, with a heavier liquid you can select different densities. If for example all the material you wanted was 3.0x heavier than water then if you dialed in a liquid with this density anything lighter would float and be waste. You could also max the range to eliminate other heavier materials (and if really lucky with the ore, get a useful byproduct). If using DMS its unlikely you would need to use a 2nd gravity concentrator system.
DMS won't be fooled by traces of clay on otherwise quality manganese ore, hence its not surprising that it generates good beneficiation results.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

The only information being presented on grade is some comments...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
2 | 5119 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online